These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27906878)

  • 21. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
    Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
    Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Glasgow Prognostic Score. An useful tool to predict survival in patients with advanced esophageal squamous cell carcinoma.
    Henry MA; Lerco MM; de Oliveira WK; Guerra AR; Rodrigues MA
    Acta Cir Bras; 2015 Aug; 30(8):580-5. PubMed ID: 26352339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher serum C-reactive protein concentration and hypoalbuminemia are poor prognostic indicators in patients with esophageal cancer undergoing radiotherapy.
    Wang CY; Hsieh MJ; Chiu YC; Li SH; Huang HW; Fang FM; Huang YJ
    Radiother Oncol; 2009 Aug; 92(2):270-5. PubMed ID: 19195729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.
    Wang Z; Liu H; Shen Z; Wang X; Zhang H; Qin J; Xu J; Sun Y; Qin X
    BMC Cancer; 2015 Oct; 15():766. PubMed ID: 26497045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer.
    Guillem P; Triboulet JP
    Dis Esophagus; 2005; 18(3):146-50. PubMed ID: 16045574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
    J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated serum synuclein-gamma in patients with gastrointestinal and esophageal carcinomas.
    Liu C; Ma H; Qu L; Wu J; Meng L; Shou C
    Hepatogastroenterology; 2012 Oct; 59(119):2222-7. PubMed ID: 22440249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma.
    Ikeda M; Natsugoe S; Ueno S; Baba M; Aikou T
    Ann Surg; 2003 Aug; 238(2):197-202. PubMed ID: 12894012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
    Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
    BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment.
    Lindenmann J; Fink-Neuboeck N; Koesslbacher M; Pichler M; Stojakovic T; Roller RE; Maier A; Anegg U; Smolle J; Smolle-Juettner FM
    J Surg Oncol; 2014 Nov; 110(6):645-50. PubMed ID: 24975677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
    J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
    Wang B; Hendricks DT; Wamunyokoli F; Parker MI
    Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression and clinical significance of chemokine receptor CXCR2 in hepatocellular carcinoma.
    Liu Z; Yang L; Xu J; Zhang X; Wang B
    J Surg Res; 2011 Apr; 166(2):241-6. PubMed ID: 20018298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble interleukin-2 receptor in serum of patients with esophageal carcinoma.
    Jabłońska E; Kozłowski M; Pietruska Z; Furman M
    Neoplasma; 1994; 41(6):315-8. PubMed ID: 7870214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro.
    Li Z; Wang Y; Dong S; Ge C; Xiao Y; Li R; Ma X; Xue Y; Zhang Q; Lv J; Tan Q; Zhu Z; Song X; Tan J
    Cytokine; 2014 Sep; 69(1):6-13. PubMed ID: 25022956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.